Adamas Announces New Employment Inducement Grant

Rhea-AI Summary

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) has granted stock options for 161,000 shares and restricted stock units for 80,500 shares to four new employees. The stock options, priced at $4.45 per share, will vest over four years. This initiative is part of the 2016 Inducement Plan approved by the board to attract talent.

This move aims to strengthen the company’s workforce as it continues to focus on delivering innovative treatments for neurological diseases.

Positive

• Granting of stock options and restricted stock units indicates a strategic focus on attracting and retaining talent.
• The stock options are set at a competitive exercise price of $4.45, aligning employee interests with company performance.

Negative

• None.

EMERYVILLE, Calif., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new employees the option to purchase an aggregate of 161,000 shares of the company’s common stock, at a per share exercise price of $4.45, the closing trading price on October 7, and restricted stock units to acquire 80,500 shares of the company’s common stock. The stock options and restricted stock units vest over four years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc. 

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Contact:

Investors:
Peter Vozzo
Westwicke Partners
443-213-0505
peter.vozzo@westwicke.com

Media:
Sarah Mathieson
Vice President, Communications & Engagement
510-450-3528
smathieson@adamaspharma.com

FAQ

What is the stock symbol for Adamas Pharmaceuticals?

The stock symbol for Adamas Pharmaceuticals is ADMS.

What recent stock options were granted by Adamas Pharmaceuticals?

Adamas Pharmaceuticals recently granted options to purchase 161,000 shares at $4.45 each.

When were the stock options for Adamas Pharmaceuticals employees granted?

The stock options were granted on October 9, 2020.

How many restricted stock units were granted by Adamas Pharmaceuticals?

Adamas Pharmaceuticals granted 80,500 restricted stock units to new employees.

What is the vesting period for Adamas Pharmaceuticals' stock options?

The stock options granted by Adamas Pharmaceuticals vest over four years.